Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Accounts Payables (2017 - 2025)

Organogenesis Holdings has reported Accounts Payables over the past 9 years, most recently at $31.9 million for Q4 2025.

  • Quarterly results put Accounts Payables at $31.9 million for Q4 2025, up 10.51% from a year ago — trailing twelve months through Dec 2025 was $31.9 million (up 10.51% YoY), and the annual figure for FY2025 was $31.9 million, up 10.51%.
  • Accounts Payables for Q4 2025 was $31.9 million at Organogenesis Holdings, down from $40.2 million in the prior quarter.
  • Over the last five years, Accounts Payables for ORGO hit a ceiling of $40.2 million in Q3 2025 and a floor of $23.2 million in Q1 2024.
  • Median Accounts Payables over the past 5 years was $29.1 million (2021), compared with a mean of $29.5 million.
  • Biggest five-year swings in Accounts Payables: dropped 29.43% in 2023 and later soared 67.78% in 2025.
  • Organogenesis Holdings' Accounts Payables stood at $29.3 million in 2021, then increased by 10.19% to $32.3 million in 2022, then fell by 4.97% to $30.7 million in 2023, then dropped by 5.9% to $28.9 million in 2024, then increased by 10.51% to $31.9 million in 2025.
  • The last three reported values for Accounts Payables were $31.9 million (Q4 2025), $40.2 million (Q3 2025), and $29.7 million (Q2 2025) per Business Quant data.